Recent studies have highlighted MES’s ability to modulate key oncogenic pathways, including Wnt/β-catenin and NF-κB, thereby exerting antiproliferative effects in CRC models [12,13]. This evidence concerns the gene NFKB1 and colorectal carcinoma.